Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia*

Heyland, Daren K., Dodek, Peter, Muscedere, John, Day, Andrew, Cook, Deborah·2008·Critical Care Medicine

Abstract

OBJECTIVE: To compare a strategy of combination therapy with a strategy of monotherapy with broad-spectrum antibiotics for suspected late ventilator-associated pneumonia. DESIGN: Randomized trial. SETTING: Twenty-eight intensive care units in Canada and the United States. PATIENTS: The study included 740 mechanically ventilated patients who developed suspected ventilator-associated pneumonia after 96 hrs in the intensive care unit. Patients known to be colonized or infected with Pseudomonas or methicillin-resistant Staphylococcus aureus or who were immunocompromised were excluded from the study. INTERVENTIONS: As initial unblinded therapy, patients were allocated to receive meropenem (1 g every 8 hrs) and ciprofloxacin (400 mg every 12 hrs) or meropenem alone. Before starting antibiotics, patients were also randomized to bronchoalveolar lavage with quantitative cultures or endotracheal aspirates. When culture results were available, physicians were encouraged to adjust antibiotics. Adequacy of antibiotics was defined as the organism present in the enrollment culture having in vitro susceptibility to one or more of the study antibiotics. MEASUREMENTS AND MAIN RESULTS: Baseline characteristics and etiologies of ventilator-associated pneumonia were similar in the two groups. There was no difference in 28-day mortality between the combination and monotherapy groups (relative risk = 1.05, 95% confidence interval 0.78-1.42, p = .74). Duration of intensive care unit and hospital stay, clinical and microbiological treatment response, emergence of antibiotic-resistant bacteria, isolation of Clostridium difficile in stool, and fungal colonization were also similar in the two groups. In a subgroup of patients who had infection due to Pseudomonas species, Acinetobacter species, and multidrug-resistant gram-negative bacilli at enrollment (n = 56), the adequacy of initial antibiotics (84.2% vs. 18.8%, p < .001) and microbiological eradication of infecting organisms (64.1% vs. 29.4%, p = .05) was higher in the combination group compared with the monotherapy group, but there were no differences in clinical outcomes. CONCLUSIONS: For critically ill patients who have suspected late ventilator-associated pneumonia and who are at low risk for difficult-to-treat gram-negative bacteria, monotherapy is associated with similar outcomes compared with combination therapy. For those patients at high risk of difficult-to-treat gram-negative bacteria, combination therapy is safe and may be associated with better microbiological and clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.ccm.0b013e31816203d6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 22

  1. Heyland, 1999, Am J Respir Crit Care Med, 159, 1249, 10.1164/ajrccm.159.4.9807050 · DOI · Paper page
  2. Safdar, 2005, Crit Care Med, 33, 2184, 10.1097/01.CCM.0000181731.53912.D9 · DOI · Paper page
  3. Baker, 2003, J Bronchology, 10, 7, 10.1097/00128594-200301000-00003 · doi:10.1097/00128594-200301000-00003
  4. Mathevon, 2002, Scand J Infect Dis, 34, 831, 10.1080/0036554021000026934 · DOI
  5. Steinberg, 2006, Intensive Care Med, 32, S113, 10.1007/s00134-006-0186-6 · DOI
  6. Alvarez-Lerma, 1996, Intensive Care Med, 22, 387, 10.1007/BF01712153 · DOI · Paper page
  7. Dupont, 2001, Intensive Care Med, 27, 355, 10.1007/s001340000640 · DOI · Paper page
  8. Luna, 1997, Chest, 111, 676, 10.1378/chest.111.3.676 · DOI · Paper page
  9. Kollef, 1998, Chest, 113, 412, 10.1378/chest.113.2.412 · DOI · Paper page
  10. Trouillet, 1998, Am J Respir Crit Care Med, 157, 531, 10.1164/ajrccm.157.2.9705064 · DOI · Paper page
  11. 2005, Am J Respir Crit Care Med, 171, 388, 10.1164/rccm.200405-644ST · DOI · Paper page
  12. Kollef, 2005, Crit Care Med, 33, 1845, 10.1097/01.CCM.0000171849.04952.79 · DOI
  13. Heyland, 2006, N Engl J Med, 355, 2619, 10.1056/NEJMoa052904 · DOI · Paper page
  14. Knaus, 1985, Crit Care Med, 13, 818, 10.1097/00003246-198510000-00009 · DOI · Paper page
  15. Marshall, 1995, Crit Care Med, 23, 1638, 10.1097/00003246-199510000-00007 · DOI · Paper page
  16. Ely, 1999, Am J Respir Crit Care Med, 159, 439, 10.1164/ajrccm.159.2.9805120 · DOI · Paper page
  17. Fagon, 2000, Ann Intern Med, 132, 621, 10.7326/0003-4819-132-8-200004180-00004 · DOI · Paper page
  18. Lan, 1983, Biometrika, 70, 659, 10.2307/2336502 · DOI · Paper page
  19. Neuhauser, 2003, JAMA, 289, 885, 10.1001/jama.289.7.885 · DOI · Paper page
  20. Livermore, 2001, J Antimicrob Chemother, 47, 247, 10.1093/jac/47.3.247 · DOI · Paper page
  21. Paul, 2004, BMJ, 328, 668, 10.1136/bmj.38028.520995.63 · DOI · Paper page
  22. Bliziotis, 2005, CID, 41, 149, 10.1086/430912 · DOI · Paper page

Cited by

See all 202

Metadata

Authors
Heyland, D. K., Dodek, P., Muscedere, J., Day, A., & Cook, D.
Venue
Critical Care Medicine
Published
2008-03
Volume
36
Issue
3
Pages
737-744
ISSN
0090-3493 (ISSN-L)
OpenAlex
W2018554274
Cited by
202
References
2
FWCI
16.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia*. https://app.cochat.ai/papers/10.1097/01.ccm.0b013e31816203d6
The paper
Heyland, D. K., Dodek, P., Muscedere, J., Day, A., & Cook, D. (2008). Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia*. Critical Care Medicine. https://doi.org/10.1097/01.ccm.0b013e31816203d6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.